Clumax Diagnostic And Research Centre Private Limited, a active private limited company, was established on 24 November 2004 in Bangalore, Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85110KA2004PTC035092. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.67 Cr and a paid-up capital of ₹1.67 Cr.
It upholds a compliant status. Its leadership includes Balakrishnan Janardhanan (Additional Director), Srinathan Rajagopalan (Director). Past directors included Suthamally Ramanan, Raju Venkatraman, Krishna Madireddy Mohan. It holds ₹201.90 Cr open charges and ₹318.83 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.68/150/3,Srilakshmitowers'9Thmainroad,3Rdblock,Jayanagar, Bangalore, Karnataka, 560011.
U85110KA2004PTC035092
035092
24 November 2004
₹1.67 Cr
₹1.67 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Clumax Diagnostic And Research Centre Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balakrishnan Janardhanan | Additional Director | 05 Jun 2025 | Current |
| Srinathan Rajagopalan | Director | 27 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Dec 2022 | Past |
| Pramod Abcsdd | Managing Director | 01 Apr 2014 | Past |
| Pramod Abcsdd | Director | 01 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 22 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 06 May 2024 | Past |
| Pramod Abcsdd | Director | 25 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clumax Diagnostic And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.7% increase. The company also saw a substantial improvement in profitability, with a 81.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Clumax Diagnostic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,019,000,000.00
₹3,188,340,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Feb 2021 | Others | ₹4.20 Cr | Open |
| 23 Apr 2019 | Others | ₹92.20 Cr | Open |
| 28 Jan 2019 | Axis Bank Limited | ₹105.50 Cr | Open |
| 13 May 2020 | The Catholic Syrian Bank Ltd | ₹10.00 Cr | Satisfied |
| 21 Aug 2017 | Hdfc Bank Limited | ₹170.28 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Clumax Diagnostic And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Clumax Diagnostic And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clumax Diagnostic And Research Centre's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Srinathan Rajagopalan was appointed as a Director was appointed as a Director on 27 Sep 2025 & has been associated with this company since 3 months 1 day . was documented.
Balakrishnan Janardhanan was appointed as a Additional Director was appointed as a Additional Director on 05 Jun 2025 & has been associated with this company since 6 months 24 days . was recorded as a recent event.
Clumax Diagnostic And Research Centre Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Clumax Diagnostic And Research Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on A charge registered on 13 May 2020 via Charge ID 100336560 with The Catholic Syrian Bank Ltd was fully satisfied on 30 Apr 2022. was documented.
A charge with Others of Rs. 92.20 Cr registered on 23 Apr 2019 with Charge ID 100260673 was modified on 22 Sep 2021. was recorded as a recent event.
When you thought you had a deal with Constellation Alpha but it fell through, so now Fosun International is trying to buy Medall Healthcare. They haven't made an offer yet, but they're interested. Medall is a big player in South India with 185 labs and they make money from radiology services too. Private equity investors want to sell their stakes and make big bucks. Fosun is already investing in India and they're trying to expand their portfolio..
When you tryna buy a company but you ain't got the cash, so you make a special company just for buying other companies. #CNAC #SPAC #moneytalks.
KKR will lend about Rs350-400 crore to Sandeep Reddy, who is negotiating with Peepul Capital's global investors to buy out Medall Healthcare.
The CIN of Clumax Diagnostic And Research Centre Private Limited is U85110KA2004PTC035092.
Clumax Diagnostic And Research Centre Private Limited is headquartered at No.68/150/3,Srilakshmitowers'9Thmainroad,3Rdblock,Jayanagar, Bangalore, Karnataka, 560011.
Clumax Diagnostic And Research Centre Private Limited was incorporated on 24 November 2004.
The current directors of Clumax Diagnostic And Research Centre Private Limited are
The primary industry of Clumax Diagnostic And Research Centre Private Limited is Hospital And Medical Care.
Clumax Diagnostic And Research Centre Private Limited is unlisted.
The authorized capital of Clumax Diagnostic And Research Centre Private Limited is ₹1.67 Cr, and the paid-up capital is ₹1.67 Cr.
The compliance status of Clumax Diagnostic And Research Centre Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX